Dissociative drugs are a class of substances that distort perceptions of sight and sound while creating a feeling of detachment from your body and surroundings. They work primarily by blocking a specific type of receptor in the brain involved in pain signaling, memory, and emotion. The most well-known dissociatives are ketamine, PCP, dextromethorphan (DXM), and salvia divinorum, though several others exist. Some have legitimate medical uses, while others are used almost exclusively recreationally.
How Dissociatives Affect the Brain
Most dissociative drugs share a common target: the NMDA receptor, which normally helps transmit signals between nerve cells using glutamate, the brain’s primary excitatory chemical messenger. Dissociatives physically block the channel inside this receptor, preventing calcium from flowing through and disrupting normal communication between neurons. This blockade is what produces the characteristic “disconnected” feeling, as the brain’s ability to integrate sensory information with your sense of self is temporarily impaired.
The disruption doesn’t stop at one receptor system. Ketamine, for example, also influences dopamine, serotonin, and opioid pathways, which helps explain why its effects extend well beyond simple numbness into mood changes, altered time perception, and even visual distortions. The NMDA receptors these drugs target are concentrated in brain regions responsible for higher-level thinking, memory formation, and sensory processing, particularly the cortex and hippocampus.
The Major Dissociative Substances
Ketamine
Ketamine was originally developed as an anesthetic and remains FDA-approved for that purpose. It’s widely used in surgical, operative, and emergency trauma settings because it provides pain relief and sedation without suppressing breathing as much as other anesthetics. At lower doses, it produces a floating sensation and mild sensory distortion. At high doses, users report what’s called a “K-hole,” a state of near-complete sensory detachment often described as terrifying, with immobility, amnesia, and feelings likened to a near-death experience. Ketamine is a Schedule III controlled substance in the United States, meaning it has accepted medical uses but carries a moderate risk of dependence.
PCP
Phencyclidine was also originally an anesthetic but was pulled from human medical use because of its severe and unpredictable psychological effects. At moderate to high doses, PCP can trigger seizures, extreme muscle contractions, aggressive or violent behavior, and psychotic symptoms that closely resemble schizophrenia. Users often feel profoundly estranged from their surroundings. PCP’s effects can last for hours, and some users report feeling them for days. It is a Schedule II substance, reflecting both its high potential for abuse and the absence of common medical applications.
Dextromethorphan (DXM)
DXM is the active cough suppressant found in many over-the-counter cold medicines. At the low doses found in a normal dose of cough syrup, it simply suppresses coughing. But at recreational doses of 300 to over 1,500 milligrams (far beyond the recommended amount), it blocks the same NMDA receptors as ketamine and PCP. Users describe a set of distinct levels, sometimes called “plateaus.” At roughly 500 to 1,000 milligrams, visual and auditory disturbances begin along with partial dissociation. Above 1,000 milligrams, full dissociation, hallucinations, and delusions can occur. A significant additional danger is that cough medicines often contain antihistamines and other active ingredients that, at these doses, can cause respiratory distress, seizures, and dangerous increases in heart rate.
Salvia Divinorum
Salvia stands apart from the other dissociatives because it doesn’t touch NMDA receptors at all. Its active compound works by activating kappa-opioid receptors, the same receptors targeted by the body’s own dynorphin molecules. The experience is distinct: intense visual and auditory hallucinations, elaborate visions, and a dramatic loss of contact with external reality. At high doses, users become completely unresponsive to visual and verbal cues from people around them, with a profound loss of body awareness and sense of body ownership. The effects come on rapidly and are relatively short-lived compared to other dissociatives. Researchers believe salvia’s mechanism suggests the kappa-opioid system plays a larger role in regulating sensory perception and the sense of self than was previously understood.
What Dissociatives Feel Like
At low to moderate doses, dissociative drugs tend to produce numbness, dizziness, nausea, and changes in how you perceive sight, sound, shapes, time, and your own body. There’s a characteristic feeling of floating or watching yourself from outside, along with memory gaps. Many users describe a sense of unreality, as though the world around them has become artificial or dreamlike.
At higher doses, the experience intensifies dramatically. Hallucinations become more vivid, coordination deteriorates, and confusion and disorientation set in. Blood pressure, heart rate, breathing rate, and body temperature all increase. Psychological effects can include extreme panic, fear, paranoia, and feelings of invulnerability or exaggerated strength. Combining dissociatives with alcohol or other depressants at high doses can suppress breathing to the point of respiratory arrest.
The onset of effects typically begins within minutes of ingestion and lasts several hours, though this varies by substance and dose.
Long-Term Physical Damage
Chronic use of dissociatives, particularly ketamine, causes cumulative harm that goes well beyond the brain. About half of regular ketamine users develop lower urinary tract symptoms, a condition known as ketamine cystitis. The drug causes severe irritation and transmural inflammation of the bladder lining, progressively destroying muscle tissue and replacing it with scar tissue. This unfolds in stages: in the first two years, inflammatory irritation predominates. Between two and four years of regular use, the bladder wall begins to thicken and bladder capacity shrinks. Eventually, the bladder becomes fibrotic and contracted, sometimes irreversibly. Imaging in chronic users frequently reveals a thickened bladder wall, reduced bladder capacity, and swelling of the ureters (the tubes connecting the kidneys to the bladder) in roughly half of cases.
The damage can extend upward to the kidneys, but there is some capacity for recovery. Ketamine abstinence for more than one year has been associated with resolution of kidney-related complications like hydronephrosis, where urine backs up and swells the kidney. Bladder fibrosis at advanced stages, however, may not reverse.
Cognitive effects from chronic use include persistent memory impairment, difficulty concentrating, and slowed reaction times. These can linger well beyond the period of active use, particularly with PCP and ketamine.
Medical and Therapeutic Uses
Two dissociative drugs currently hold FDA approval. Ketamine is approved as an anesthetic, and esketamine (a refined version of the ketamine molecule) was brought to market around 2019 specifically for treatment-resistant depression, meaning depression that hasn’t responded to standard medications. Several studies have demonstrated that ketamine can significantly improve depressive symptoms in patients who haven’t benefited from conventional antidepressants, often with effects noticeable within hours rather than the weeks typical of standard medications.
Beyond these approved uses, ketamine is prescribed off-label for chronic pain, anxiety, and other conditions, though these applications lack formal FDA endorsement. The broader landscape of dissociative and psychedelic research is active, with ongoing studies examining whether related compounds can reduce anxiety and depression in cancer patients and promote well-being and quality of life in other populations.
Risks Specific to Over-the-Counter Access
DXM occupies a unique position among dissociatives because it’s legally available without a prescription in cough and cold medications. Achieving dissociative effects requires consuming roughly 18 to 33 capsules or 185 to 375 milliliters of cough syrup at minimum, with higher “plateaus” requiring even more. The practical danger is that these products are formulated for standard dosing and contain other active ingredients, particularly acetaminophen and antihistamines, that become toxic at the quantities needed for dissociative effects. Acetaminophen overdose can cause fatal liver damage. Antihistamines at these levels increase the risk of seizures, dangerous heart rhythms, and respiratory failure. The dissociative effects of DXM itself are similar to PCP and ketamine, but the packaging alongside other compounds makes high-dose DXM use particularly hazardous.